SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs informs about approval of products

16 Apr 2021 Evaluate

Vivimed Labs has informed that it received approvals for the following 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site: Bilastine tablets 20mg under brand name FLUSTIN; Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI; and Paracetamol 12Smg/ Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name FEBRIL.

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

6.10 0.03 (0.49%)
12-Jun-2026 11:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.00
Dr. Reddys Lab 1273.00
Cipla 1394.10
Zydus Lifesciences 1109.00
Lupin 2286.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: